On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.

NetworkNewsBreaks – Pressure BioSciences, Inc. (PBIO) Sets Teleconference to Discuss FY2017 Results

Company: Pressure BioSciences, Inc. (PBIO)
Category: News

Global life sciences company Pressure BioSciences, Inc. (OTCQB: PBIO) this morning announced that it plans to host a teleconference to discuss its fourth quarter and fiscal year 2017 financial results and to provide a business update. The teleconference is scheduled for Tuesday, April 3, 2018, at 4:30 PM EDT. Those interested in participating in the call can do so live by dialing (877) 407-8031 in North America or (201) 689-8031 from international locations. The verbal passcode for the teleconference is ‘PBI Fourth Quarter and FY2017 Financial Call & Business Update’. A replay of the call will be made available beginning Wednesday, April 4, 2018, for those unable to participate in the live teleconference. This replay will be accessible via telephone and the company’s website for 30 days. The replay will be reviewable by dialing (877) 481-4010 in North America or (919) 882-2331 from international locations, using replay ID number 27377.

To view the full press release, visit http://nnw.fm/V4Rff

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (OTCQB: PBIO) is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences industry. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control bio-molecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil & plant biology, forensics, and counter-bioterror applications. For more information, visit the company’s website at www.PressureBiosciences.com

More from NetworkNewsBreaks

About NetworkNewsWire

NetworkNewsWire (NNW) is a financial news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with NNW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

For more information, please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

Contact us: 212.418.1217